FDA Approved: MEROPENEM — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for Meropenem submitted by BluePoint Laboratories (ANDA205883), confirming approval of a supplemental filing for this ge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Meningitis
• Gynecologic Infections
• Intra-abdominal Infections
• Pneumonia
• Skin and Soft Tissue Infections
• Urinary Tract Infections

Drugs mentioned

• Meropenem (Meropenem)

Snippet

SUPPL AP for MEROPENEM (MEROPENEM)